Bank of Montreal Can Boosts Position in IDEXX Laboratories, Inc.

The fund increased its stake in the veterinary diagnostics company by nearly 15% in the third quarter.

Mar. 12, 2026 at 7:21am

Got story updates? Submit your updates here. ›

Bank of Montreal Can, a major institutional investor, grew its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 14.9% during the third quarter of 2026, according to a recent SEC filing. The fund now owns 139,126 shares of the company's stock, worth approximately $88.9 million.

Why it matters

IDEXX Laboratories is a leading global provider of diagnostic products and services for the animal health, water testing, and food safety markets. The company's strong performance and growth potential have attracted significant investor interest, with major funds like Bank of Montreal Can increasing their stakes.

The details

According to the 13F filing, Bank of Montreal Can purchased an additional 18,025 shares of IDEXX Laboratories during the third quarter, bringing its total position to 139,126 shares. This represents approximately 0.17% of the company's outstanding shares.

  • Bank of Montreal Can filed the 13F report disclosing the increased stake in IDEXX Laboratories on March 12, 2026.
  • The reported transactions occurred during the third quarter of 2026.

The players

Bank of Montreal Can

A major Canadian financial institution and institutional investor.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to closely monitor and analyze the performance of our portfolio holdings to identify opportunities for growth and value creation.”

— Unspecified Bank of Montreal Can spokesperson

The takeaway

The increased investment by Bank of Montreal Can in IDEXX Laboratories reflects the veterinary diagnostics company's strong market position and growth potential. As a leading player in the animal health and food safety industries, IDEXX's continued success is likely to attract further institutional investor interest.